Increased expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured endothelial cells exposed to serum from type 1 diabetic patients: no effects of high glucose concentrations

REFERENCES

• Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen-year follow-up study. Diabetes 1974; 23: 105–11.
   Google Scholar
• Dubrey SW, Reaveley DR, Seed M, Lane DA, Ireland H, O'Donnell M, O'Connor B, Noble MI, Leslie RD. Risk factors for cardiovascular disease in IDDM. A study of identical twins. Diabetes 1994; 43: 831–5.
   Google Scholar
• Laakso M, Ronnemaa T, Lehto S, Puukka P, Kallio V, Pyorala K. Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations? Diabetologia 1995; 38: 487–93.
   PubMed Web of Science ®Google Scholar
• Andresen JL, Rasmussen LM, Ledet T. Diabetic macroangiopathy and atherosclerosis. Diabetes 1996; 45 Suppl 3: S91—S4.
   Google Scholar
• Rasmussen LM, Heickendorff L. Quantification of fibronectin in extracts of human aortae by an ELISA. Scand J Clin Lab Invest 1989; 49: 205–10.
   PubMed Web of Science ®Google Scholar
• Dybdahl H, Ledet T. Diabetic macroangiopathy. Quantitative histopathological studies of the extra-mural coronary arteries from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1987; 30: 882–6.
   Google Scholar
• Heickendorff L, Ledet T, Rasmussen LM. Glyco-saminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque. Diabetologia 1994; 37: 286–92.
   Google Scholar
• Rasmussen LM, Ledet T. Aortic collagen altera-tions in human diabetes mellitus. Changes in basement membrane collagen content and in the susceptibility of total collagen to cyanogen bromide solubilisation. Diabetologia 1993; 36: 445–53.
   Google Scholar
• Takemoto M, Yokote K, Nishimura M, Shigematsu T, Hasegawa T, Kon S, Uede T, Matsumoto T, Saito Y, Mori S. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler Thromb Vasc Biol 2000; 20: 624–8.
   PubMed Web of Science ®Google Scholar
• Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996; 16: 978–83.
   Google Scholar
• Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are asso-ciated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 1995; 91: 1432–43.
   Google Scholar
• Oxlund H, Rasmussen LM, Andreassen TT, Heickendorff L. Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 748–52.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis—an inflammatory dis-ease. N Engl J Med 1999; 340: 115–26.
   PubMed Web of Science ®Google Scholar
• Wang J, Springer TA. Structural specializations of immunoglobulin superfamily members for adhe-sion to integrins and viruses. Immunol Rev 1998; 163: 197–215.
   PubMed Web of Science ®Google Scholar
• Kansas GS. Selectins and their ligands: current concepts and controversies. Blood 1996; 88: 3259–87.
   PubMed Web of Science ®Google Scholar
• Huo Y, Ley K. Adhesion molecules and athero-genesis. Acta Physiol Scand 2001; 173: 35–43.
   PubMedGoogle Scholar
• Moreno PR, Murcia AM, Palacios IF, Leon MN, Bernardi VH, Fuster V, Fallon JT. Coronary composition and macrophage infiltration in ather-ectomy specimens from patients with diabetes mellitus. Circulation 2000; 102: 2180–4.
   Google Scholar
• Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 1998; 101: 1905–15.
   Google Scholar
• Ribau JC, Hadcock SJ, Teoh K, DeReske M, Richardson M. Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients. J Surg Res 1999; 85: 225–33.
   Google Scholar
• Richardson M, Hadcock SJ, DeReske M, Cybulsky MI. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rab-bits. Arterioscler Thromb 1994; 14: 760–9.
   PubMed Web of Science ®Google Scholar
• Clausen P, Jacobsen P, Rossing K, Jensen JS, Parving HH, Feldt-Rasmussen B. Plasma concen-trations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet Med 2000; 17: 644–9.
   Google Scholar
• Schmidt AM, Crandall J, Hori 0, Cao R, Lakatta E. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunc-tion and progressive vascular disease. Br J Haematol 1996; 92: 747–50.
   Google Scholar
• Koga M, Otsuki M, Kubo M, Hashimoto J, Kasayama S. Relationship between circulating vascular cell adhesion molecule-1 and microvas-cular complications in type 2 diabetes mellitus. Diabet Med 1998; 15: 661–7.
   Google Scholar
• Fries JW, Williams AJ, Atkins RC, Newman W, Lipscomb MF, Collins T. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol 1993; 143: 725–37.
   PubMed Web of Science ®Google Scholar
• Rasmussen LM, Hansen PR, Nabipour MT, Olesen P, Kristiansen MT, Ledet T. Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells. Biochem J 2001; 360: 363–70.
   PubMed Web of Science ®Google Scholar
• Elhage R, Maret A, Pieraggi MT, Thiers JC, Arnal JF, Bayard F. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation 1998; 97: 242–4.
   PubMed Web of Science ®Google Scholar
• Read MA, Whitley MZ, Williams AJ, Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503–12.
   PubMed Web of Science ®Google Scholar
• Lechleitner M, Koch T, Herold M, Dzien A, Hoppichler F. Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med 2000; 248: 67–76.
   Google Scholar
• Zoppini G, Faccini G, Muggeo M, Zenari L, Falezza G, Targher G. Elevated plasma levels of soluble receptors of TNF-alpha and their associa-tion with smoking and microvascular complica-tions in young adults with type 1 diabetes. J Clin Endocrinol Metab 2001; 86: 3805–8.
   PubMed Web of Science ®Google Scholar
• Turner RC, The UK. Prospective Diabetes Study. A review. Diabetes Care 1998; 21 Suppl 3: C35 —C8.
   Google Scholar
• Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA. Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 2002; 90: 107–11.
   Google Scholar
• Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 2002; 51: 159–67.
   Google Scholar
• Rasmussen LM, Ledet T. Serum from diabetic patients enhances synthesis of arterial basement membrane-like material in cultured smooth muscle cells. APMIS 1988; 96: 77–83.
   PubMed Web of Science ®Google Scholar
• Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-a and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterio s-cler Thomb Vasc Biol 1998; 18: 1199–202.
   Google Scholar
• Winkler G, Salamon F, Salamon D, Speer G, Simon K, Cseh K. Elevated serum tumor necrosis factor-a levels can contribute to the insulin resistance in type 2 (non-insulin-dependent) dia-betes and in obesity. Diabetologia 1998; 41: 860–2.
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Hon i 0, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule4 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96: 1395 —403.
   Google Scholar
• Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassar a H. Advanced protein glyco sylation induces transendothelial human monocyte chemo-taxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87: 9010 — 14.
   Google Scholar